Review of low-grade gliomas in children—evolving molecular era and therapeutic insights

Soumen Khatua, Jason Wang, Veena Rajaram

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


Low-grade gliomas are the commonest brain tumor in children comprising heterogeneous pathological entities. Though the overall prognosis is good, unresectable, and recurrent or progressive tumors in eloquent areas of the brain remain major therapeutic challenge even with advances in chemotherapeutic strategies. With the evolving surge of molecular data, improved understanding of the biology of these tumors is now perceivable that could provide insights into novel therapies. We hope the new era will enable us to profile comprehensive histopathological/molecular classification and prognostic molecular markers in these tumors and guide us to tailor optimal targeted therapy.

Original languageEnglish (US)
Pages (from-to)643-652
Number of pages10
JournalChild's Nervous System
Issue number5
StatePublished - May 1 2015


  • Histopathology
  • Low-grade gliomas
  • Molecular biology
  • Therapeutic insights

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Clinical Neurology


Dive into the research topics of 'Review of low-grade gliomas in children—evolving molecular era and therapeutic insights'. Together they form a unique fingerprint.

Cite this